Our products

Our products are focused on the therapeutic areas genetic and metabolic diseases and oncology and hematology. We also have a portfolio of speciality care products. 

Please note that Immedica distributes the products mentioned only in designated geographical areas and that all products may not be available in all countries. Additionally, currently approved indications and presentations may differ between countries.

Akynzeo®
(Netupitant-Palonosetron fixed combination)

European Medicines Agency (English)

Read more
Aloxi®
(Palonosetron)

European Medicines Agency (English)

Read more
Ammonaps®
(Sodium Phenylbutyrate)

European Medicines Agency (English)

Read more
Arlevert®
(cinnarizine / dimenhydrinate)

FASS för vårdgivare (Swedish)

Read more
Loargys®
(pegzilarginase)

European Medicines Agency (English)

Read more
Neofordex®
(dexamethasone)

European Medicines Agency (English)

Read more
Nor-NOHA Blood Collection Tubes
Read more
Orphacol®
(cholic acid)

European Medicines Agency (English)

Read more
Ravicti®
(glycerol phenylbutyrate)

European Medicines Agency (English)

Read more
Vertisan®
(betahistine dihydrochloride)

FASS för vårdgivare (Swedish)

Read more
Yondelis®
(trabectedin)

European Medicines Agency (English)

Read more
Unlicensed products

Immedica is distributing a number of unlicensed drugs within Europe and the Middle East. For information regarding a specific product please contact our Medical Department via [email protected]